Highlights:
- COVID-19 causes “widespread disruption” to neuroendovascular research around the globe
- Stroke risk found higher in patients with COVID-19 than influenza
- Thrombectomy proved efficacious in Latin America as the final results of RESILIENT are published
- Profile: Richard P Klucznik (Houston, USA)
- Neuromodulation: Non-invasive vagus nerve stimulation (VNS) may provide clinical benefit to patients with COVID-19
